Download CombiGene: Newly-appointed CEO accepts offer to purchase options

PRESS RELEASE
Lund, Nov 28 2016
CombiGene: Newly-appointed CEO
accepts offer to purchase options
CombiGene’s newly-appointed CEO, Jan Nilsson, accepts an offer to
purchases options within the framework of the options programme
which was decided upon at the annual general meeting held on 4
April 2016. Jan Nilsson purchases 60,000 options from the options
programme, which is 100 per cent of the offer. In addition to the
purchase from the options programme, Jan Nilsson purchases a further
60,000 options from his predecessor as CEO.
“The purchase of 120,000 options in
total reflects both the strong enthusiasm I feel at the prospect of my assignment as CEO and my optimistic
view of CombiGene’s potential”, says
Jan Nilsson in a comment.
The information in this press release is such that CombiGene AB is obliged to publish pursuant to EU’s regulation on market abuse.
The information was delivered, by the chairman, Arne Ferstad, for public dissemination on the 28th November 2016.
About CombiGene AB
For further information:
By combining modern neuroscience with recent advances in
gene delivery, CombiGene has developed a method shown
to suppress epileptic seizures in preclinical studies. The
current focus is on continuing to develop this method into
an effective and safe therapy for epilepsy patients, but the
method may also have development potential as a means of
treating other neurological disorders. Founded on the basis
of scientific discoveries made at Lund University and the
University of Copenhagen, CombiGene has offices at Medicon
Village in Lund, Sweden. The company is public and listed on
the Swedish marketplace AktieTorget. www.combigene.com
CombiGene AB (publ)
Arne Ferstad, Chairman of the Board
Tel: +46 72 - 206 97 25
email: [email protected]
Please read MORE FROM THE COMPANY, a newsletter
from CombiGene which contains general news and information that is judged not to have a significant effect on
the share price. Other issues of MORE FROM THE COMPANY
and press releases are available at www.combigene.com
www.combigene.com
CombiGene AB (publ) Medicon Village, SE-223 81 Lund, Sweden [email protected]
1
w w w.combigene.com